2026 Optiq-V electrifies Cadillac's lauded performance line with 519 hp
Cadillac's V-series performance line goes electric with a 73% power increase to the brand's new Optiq compact SUV.
The Optiq-V accelerates to 60 mph in 3.5-seconds and goes on sale this fall.
Priced at $67,300, plus $1,495 destination charge, the Optiq-V will compete with sporty compact SUVs from Mercedes-AMG, BMW M Sport and Lexus F-Sport. Based on what we know now ― price, looks and features ― it could be a formidable competitor.
In addition to a whopping 219 horsepower increase from two new electric motors, the all-wheel-drive Optiq-V gets continuously adaptive ZF shock absorbers and aerodynamic upgrades.
The V-series, now in its fifth generation, accounts for about 10% of Cadillac sales.
519 hp
650 pound-feet of torque
85 kWh battery
275-mile manufacturer-estimated range
33-inch display/touch screen
19-speaker AKG audio
21-inch wheels
The Optiq-V's twin electric motors ― one on each axle for AWD ― are the ones used in Cadillac's midsize Lyriq EV. They're bigger than the base Optiq, which produces 300 hp and 354 pound-feet of torque. The V's 10-modlue battery is the same size at the base Optiq.
The Optiq-V gets unique performance software, including:
V-Mode, activated by a button on the steering wheel, allows the driver to program their individual preferences for sporty driving, including sound, launch control, steering, acceleration, damping and competitive mode.
Competitive Mode adjusts traction management and brake torque vectoring for sporty driving.
Launch Mode ― engages maximum power for straight-line acceleration.
Ambient lighting complements drive modes.
ZF continuously adaptive shocks and Brembo front brake calipers are standard. All-season or summer 21-inch tires are available.
Standard Super Cruise
Available summer tires
Built-in NACS charging point
Fixed glass roof
Customizable V-mode
Launch control
Dolby Atmos compatible audio
Brake torque vectoring of front and rear axles
Black roof
The V-package also includes a black roof. Other visual touches include blue exterior accents, optional red or blue front brake calipers that have the V-series logo, which is repeated inside out. The V gets two exclusive colors: Magnus Metal Frost and Deep Ocean Tintcoat. Blue seat belts and seat backs are available.
A carbon fiber package includes a rear spoiler and front valence.
Cadillac will sell the Optiq-V in the United States, Canada, Mexico and the Middle East. It'll be the first General Motors vehicle with a factory-installed NACS charging port for access to Tesla DC chargers. An adapter will be available for CCS ports.
2026 Cadillac Optiq-V at a glance
All-wheel drive five-seat luxury performance SUV
Base price: $67,300 (All prices exclude $1,450 destination charge)
On sale Fall 2025
Power: Two electric motors, one on each axle
Output: 519 hp; 650 pound-feet of torque
Transmission: Single-speed automatic
Battery: 85 kWh lithium-ion
Charging time: 240v: 18-31 miles an hour; DC fast charge: 70 miles in 10 minutes.
0-60 mph: 3.5 seconds
Wheelbase: 116 inches inches
Length: 190 inches
Width: 84 inches including mirrors
Height: 65 inches
Passenger volume: 100.1 cubic feet
Cargo capacity: 26 cubic feet behind second row, 57 behind first row
Towing capacity: None
Curb weight: 5,445 pounds
Assembled in Ramos Arizpe, Mexico
Contact Mark Phelan: mmphelan@freepress.com. Follow him on Twitter mark_phelan. Read more on autos and sign up for our autos newsletter. Become a subscriber.
This story has been updated to add a gallery.
This article originally appeared on Detroit Free Press: Cadillac's famous V-series goes electric with a 519-hp SUV
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Carlton Precious Announces Further Upsize to Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI | OTCQB: NBRFF) ("Carlton" or the "Company") is pleased to announce that, further to its press releases of May 12, 2025, and May 23, 2025, the Company has increased its non-brokered private placement to up to 18,700,000 units (each, a "Unit") in the capital of the Company at a price of $0.09 per Unit for gross proceeds of up to $1,683,000 (the "Private Placement"). Each Unit shall be comprised of one common share (each, a "Common Share") in capital of the Company and one-half of one whole Common Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant entitles the holder therefor to acquire one Common Share at a price of $0.12 per Common Share for a period of 24 months from the date of issuance. In connection with the Private Placement, the Company may pay certain eligible persons (the "Finders") a cash commission equal to 7% of the gross proceeds of the Private Placement and issue broker warrants (each, a "Broker Warrant") equal to 7% of the number of Units issued pursuant to the Private Placement. Each Broker Warrant entitles the holder thereof to acquire one Common Share at a price of $0.09 per Common Share for a period of 24 months from the date of issuance. In addition, certain eligible Finders shall receive Units equal to 7% of the number of Units issued pursuant to the Private Placement. Net proceeds of the Private Placement will be utilized to commence a drilling program at the Company's wholly-owned Esquilache Project in Peru and for general working capital purposes. All securities issued in connection with the Private Placement will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons as defined under applicable United States securities laws unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. About Carlton Precious Inc. Carlton Precious is a publicly traded precious and base metals exploration company listed on the TSX Venture Exchange. The Company is managed by a team of experienced mining and geological professionals. Carlton Precious' projects are focused on key mining jurisdictions including Peru and Australia (central Victoria and Tasmania). For further information, please contact: Martin Walter, CEO, Carlton Precious Inc., at +1-416-389-5692 or martin@ Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution Regarding Forward Looking Statements This news release contains certain "forward-looking information" within the meaning of applicable securities laws. Forward looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "would", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward- looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 hours ago
- Business Wire
Spanish Mountain Gold Announces Grant of Stock Options
VANCOUVER, British Columbia--(BUSINESS WIRE)--Spanish Mountain Gold Ltd. (the " Company" or " Spanish Mountain Gold") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) announces that it has granted 2,860,500 stock options to officers and directors of the Company and 221,500 stock options to employees and consultants pursuant to the terms of the Company's stock option plan. Each option entitles the holder to acquire one Common Share at an exercise price of $0.175 per Common Share for ten years. About Spanish Mountain Gold Ltd. Spanish Mountain Gold Ltd. is focused on advancing its 100%-owned Spanish Mountain Gold Project (Project) towards construction of the next gold mine in the Cariboo Gold Corridor, British Columbia. The Company expects to release at the end of Q2, 2025, the results for the Project's newly de-risked and optimized Preliminary Economic Assessment (PEA) with an updated Mineral Resource Estimate (MRE). Upon receipt of the new PEA and updated MRE, the company will decide the next steps to advance the Project to position the company to make a construction decision in or before 2027. We are striving to be a leader in community and Indigenous relations by leveraging technology and innovation to build the 'greenest' gold mine in Canada. The Relentless Pursuit for Better Gold means seeking new ways to achieve optimal financial outcomes that are safer, minimize environmental impact and create meaningful sustainability for communities. Details on the Company are available on and on the Company's website: On Behalf of the Board, 'Peter Mah' President, Chief Executive Officer and Director Spanish Mountain Gold Ltd. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. FORWARD-LOOKING INFORMATION: Certain of the statements and information in this press release constitute "forward-looking information". Any statements or information that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects", "anticipates", "believes", "plans", "estimates", "intends", "targets", "goals", "forecasts", "objectives", "potential" or variations thereof or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be considered forward-looking information. The Company's forward-looking information is based on the assumptions, beliefs, expectations and opinions of management as of the date of this press release and include but are not limited to information with respect to, the potential to extend mineralization within the near-surface environment; the potential to expand resources and to find higher-grade mineralization at depth; the timing, size and budget of a winter drill program, and the results thereof; and the delivery of a maiden resource for the Phoenix Target, and the timing and results thereof. Other than as required by applicable securities laws, the Company does not assume any obligation to update forward-looking information if circumstances or management's assumptions, beliefs, expectations or opinions should change, or changes in any other events affecting such statements or information. For the reasons set forth above, investors should not place undue reliance on forward-looking information.
Yahoo
2 hours ago
- Yahoo
MedX Announces Final Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario, June 09, 2025--(BUSINESS WIRE)--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closing and further Closing, it has completed a final Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Final Closing comprised the issuance of 8,678,571 Units (as described below) and raised cash proceeds of $607,500, bringing the total amount raised in the Placement to $2,063,500. Securities issued are subject to a regulatory "hold" period of four months and one day from the date of issuance. Under this Non-Brokered Private Placement, the Company issued a total of 29,478,571 Units at $0.07 per Unit ("Unit"). Each Unit is comprised of One (1) fully paid common share and One (1) Share Purchase Warrant ("Warrant(s)"), exercisable to purchase One (1) further Common Share at the price of $0.09, during the period of one year commencing on the date of issuance. Three Insiders participated in this Placement to the extent of $500,000, for the acquisition of a total of 7,142,857 Units. In connection with the issuance of Units to those Insiders, the Company relies on exemptions from formal valuation and minority shareholder approval requirements set out in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). as (i) the fair market value of the proposed placement to the Insiders does not exceed 25% of the market capitalization of the Company and (ii) the conditions in section 5.7(1)(a), section 5.7(1)(b) and section 5.7(1)(e) of MI 61-101 are met. Qualified agents received total cash commissions of $15,880, (equal to 8% of the gross proceeds received by the Company from the sale of the Units to subscribers introduced by such agent(s)), and 226,857 agent's warrants ("Agent's Warrant(s)") (equal to 8% of subscriptions introduced by such agent(s)). Each Agent's Warrant, which is non-transferable, entitles the holder to acquire, at the price of CAD$0.07, a unit, comprised of One (1) fully paid Common Share and one (1) non-transferable share purchase warrant ("Agent's Share Purchase Warrant"), entitling the holder to acquire one additional Common Share at the price of CAD$0.09. The Agent's Warrants and any Agent's Share Purchase Warrants that may be issued pursuant to exercise of an Agent's Warrant, if not exercised, will expire one year following the date of issuance. Funds raised in this Placement are being be directed towards continuing development of the Company's leading edge SIAscopy® on DermSecure® telemedicine platform, building out the launch of its technology into the occupational health marketplace, and general corporate purposes. About MedX Health Corp.: MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union and Turkey. Visit Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This Media Release may contain forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. View source version on Contacts MedX Health Druhan, President, Dermatological (+1) 905-599-7852
